Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Epithelial outgrowth through mesenchymal rings drives lung alveologenesis
Nicholas M. Negretti, … , Bryan Millis, Jennifer M.S. Sucre
Nicholas M. Negretti, … , Bryan Millis, Jennifer M.S. Sucre
Published January 7, 2025
Citation Information: JCI Insight. 2025;10(4):e187876. https://doi.org/10.1172/jci.insight.187876.
View: Text | PDF
Research Article Development Pulmonology

Epithelial outgrowth through mesenchymal rings drives lung alveologenesis

  • Text
  • PDF
Abstract

Determining how alveoli are formed and maintained is critical to understanding lung organogenesis and regeneration after injury. To study the cellular dynamics of this critical stage of lung development, we have used scanned oblique-plane illumination microscopy of living lung slices to observe alveologenesis in real time at high resolution over several days. Contrary to the prevailing notion that alveologenesis occurs by airspace subdivision via ingrowing septa, we found that alveoli form by ballooning epithelial outgrowth supported by contracting mesenchymal ring structures. Systematic analysis has produced a computational model of finely timed cellular structural changes that drive normal alveologenesis. With this model, we can now quantify how perturbing known regulatory intercellular signaling pathways and cell migration processes affects alveologenesis. In the future, this paradigm and platform can be leveraged for mechanistic studies and screening for therapies to promote lung regeneration.

Authors

Nicholas M. Negretti, Yeongseo Son, Philip Crooke, Erin J. Plosa, John T. Benjamin, Christopher S. Jetter, Claire Bunn, Nicholas Mignemi, John Marini, Alice N. Hackett, Meaghan Ransom, Shriya Garg, David Nichols, Susan H. Guttentag, Heather H. Pua, Timothy S. Blackwell, William Zacharias, David B. Frank, John A. Kozub, Anita Mahadevan-Jansen, Evan Krystofiak, Jonathan A. Kropski, Christopher V.E. Wright, Bryan Millis, Jennifer M.S. Sucre

×

Figure 2

Alveolar type 2 cells undergo changes in cell shape that are associated with differentiation into alveolar type 1 cells.

Options: View larger image (or click on image) Download as PowerPoint
Alveolar type 2 cells undergo changes in cell shape that are associated ...
PCLS from mT/mG;Sftpc-CreERT2 mice (with tamoxifen given on P3 and P4) were volumetrically imaged and displayed as a 3D projection (GFP green, tdTomato magenta), representative of n = 9 imaging movies from 3 mice. (A) 3D projection of a still image from the start of the 72-hour imaging period. (B) 3D projection of a still image from the end of the same imaging period. Scale bars: 30 μm. (C) The same Sftpc-GFP–labeled cell viewed from 3 different orientations showing the dramatic cell-shape change from round to flat over 42 hours. Scale bars: 10 μm. (D) Quantification of sphericity of individual cells in C making this transition (representative of n = 83 cells counted). (E) Lungs from mT/mG;Sftpc-CreERT2 mice given tamoxifen on P3 and P4 and harvested on P5 (left) and P7 (right), immunostained with antibodies against GFP (green) and PDPN (white), analyzed by RNA in situ hybridization for Sftpc (red), with DAPI counterstaining (blue) to mark DNA. Scale bars: 10 μm. (F) Quantification of percentage Sftpc+ and PDPN+ cells among total GFP+ cells on P5 and P7, with each data point indicating the average value from 8–10 images of an individual mouse. **P < 0.01; ***P < 0.001 by 1-tailed Student’s t test (n = 5–6 mice on P5, 8 mice on P7). (G) Sequential still frames from 4D imaging of PCLS from mT/mG;Ager-CreERT2 mice (with tamoxifen given on P3 and P4). Scale bars: 30 μm. Representative of n = 9 imaging movies from 3 mice.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts